Monitoring Ebola Virus

Columbia University is closely monitoring the current outbreak of Ebola Virus Disease (EVD) in the Democratic Republic of Congo. Currently, the Centers for Disease Control and Prevention (CDC) has not issued any travel warnings to this area. This guidance will be updated as the situation changes.

May 18, 2017

Columbia University is closely monitoring the current outbreak of Ebola Virus Disease (EVD) in the Democratic Republic of Congo. According to the Centers for Disease Control, 19 suspected cases (including 2 laboratory confirmed and 3 deaths) of Ebola have occurred since April 22, 2017, in the remote health district of Likati in the previously unaffected northern province of Bas-Uele. Investigation is ongoing, and the source of infection remains unknown. This is the first confirmed EVD case reported in the country since October 2014 and the eighth outbreak of EVD in former Zaire/present-day Democratic Republic of the Congo since 1976. More than 300,000 emergency doses of an Ebola vaccine (rVSV-ZEBOV; Merck) will be available in case of a large-scale outbreak.

Currently, the Centers for Disease Control and Prevention (CDC) has not issued any travel warnings to this area. Travelers returning from Democratic Republic of the Congo should self-monitor for 21 days after return and telephone ahead before presenting to any medical facility if they become ill.

This guidance will be updated as the situation changes.